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Abstract Associations between cholesterol and suicidal
behavior in adolescent patients have not been explored in
depth. In this study, 66 patients consecutively admitted to a
psychiatric inpatient unit following attempted suicide were
compared with a control group of 54 patients with no
history of suicide attempts. The age range of the sample
was from 8 to 18 years old. Cholesterol levels were sig-
nificantly lower in attempted suicide patients than in con-
trols (p \ 0.02), supporting the hypothesis that lower
cholesterol levels might be associated with suicidal
behavior in patients with similar acute phase of their
disorder.
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Introduction
Suicide attempts occur in various psychiatric disorders,
almost half of them (60%) in the context of depression
[6]. For decades, psychiatrists have sought biological
parameters to help them to determine and predict suicidal
risk among their patients. Studies of cerebrospinal fluid
(CSF) of depressed suicide attempters has identified lower
5-hydroxyindolacetic acid (5-HIAA) and homovanillic
acid (HVA) levels in CSF and reduced HVA/5-HIAA
ratio as useful biomarkers [7, 13, 16, 17, 28, 31]. Altered
function of serotonin transporters and the 5HT2 serotonin
receptor also suggest a higher risk of suicidality [24, 29].
Although several studies have assessed the association
between lower levels of cholesterol and suicide, the link
between peripheral cholesterol and suicidal behavior
remains unclear. One of the functions of serotonin in the
central nervous system is to avoid harmful behavioral
impulses. Engelberg’s [10] theory related alterations
in membrane microviscosity of cells with dysfunctions
in serotonin neurotransmission, and Vevera et al. [34]
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reported that lower cholesterol levels induced viscosity
alterations in the cell membrane, with secondary seroto-
ninergic receptor alterations. Lower gray-matter choles-
terol in some cortical brain areas has also been related
with violent suicide completers [22].
This research generated a conceptual framework for
molecular genetic studies on the association between
genes encoding for lipid metabolism and those related to
suicidality. However, a genetic study by Lalovic et al.
[20] failed to report significant differences in allele or
genotype frequencies of proteins involved in cholesterol
biosynthesis and transport between suicide cases and
controls. A recent study found that the ABCG1 trans-
porter may influence aggression-related traits [14]. At all
events, most research has focused on cholesterol serum
levels and the findings have been inconsistent. Differences
in the criteria used to classify patients as ‘‘suicidal’’ (only
attempters, or subjects with suicidal ideation), and dif-
ferences in criteria used to define the comparison group
make results difficult to compare. Some studies have
confirmed the association between lower levels of cho-
lesterol and suicidality [2, 4, 9, 15, 19, 21, 23, 25, 27, 30,
35], while others find only a trend [32]. However, Tans-
kanen et al. [33] demonstrated the positive relationship of
high serum total cholesterol concentration with increased
risk of violent suicide. Deisenhammer et al. [8] found no
significant differences in lipid levels between patients
with and without suicide attempts, but noted a trend
toward lower total cholesterol levels in patients who had
used a violent method; Fiedorowicz and Coryell [12]
reported no association between low cholesterol and
subsequent suicide. Some of the studies compared suicidal
psychiatric patients with the general population [3, 27,
30], while others compared suicidal and non-suicidal
patients with the same psychiatric diagnosis [4, 11, 15,
18, 19, 25, 26]. To date, we have found no studies in
adult patients that assess this relationship in composite
samples with different psychiatric diagnoses, or that
consider lower levels of cholesterol in association with
suicide attempts independently of specific psychiatric
disorders.
Focusing on adolescent psychiatric patients, only two
studies have included adolescent psychiatric samples.
Favaro et al. [11] reported an association between lower
cholesterol levels and suicidality in anorexic patients.
However, these results should be regarded with caution
because of influences of nutritional variables on cholesterol
levels in these patients. Apter et al. [1] found higher serum
cholesterol levels in a group of patients with suicidal
behavior in an adolescent inpatient sample with different
psychiatric diagnoses. In this study, the group of patients
with suicidal behavior included: patients with suicidal
ideation without suicide attempts, patients with suicidal
tendencies and patients with suicide attempts. These
authors also included eating disorder patients, who pre-
sented the highest serum cholesterol levels. In the suicidal
behavior group, serum cholesterol correlated negatively
with the degree of suicide behavior, suggesting perhaps
that cholesterol levels could be inversely related with
‘‘acting’’, that is, with the step from suicide ideation to
suicide attempt. Following on from this research, the
present study focuses only on adolescent suicide attempters
and excludes patients with suicidal ideation only, to study a
specific suicidality outcome group. The objective is to
provide further information about the potential role of
serum cholesterol levels in suicide attempters in a general
sample of psychiatric adolescent patients admitted to a
hospital unit.
Method
Subjects
This case–control retrospective study was conducted in
the inpatient unit of a Child and Adolescent Psychiatry
and Psychology Department (Hospital Clinic of Barce-
lona). Over a 4-year period (2004–2007), 66 patients (49
females and 17 males) were consecutively admitted fol-
lowing attempted suicide. For being included in the
attempted suicide group, patients must have committed an
attempt to kill themselves (a suicide attempt with suicide
ideation). Patients presenting self harm behavior without
suicidal intention were not included in this group. The
control group included 54 patients (39 females and 15
males) who were also admitted to the inpatient unit dur-
ing the same period but who had no history of suicide
attempts. Control subjects (non-suicide attempts) were
paired with case subjects (suicide attempts) according to
psychiatric diagnosis, age and gender. If no control sub-
ject with the same psychiatric diagnosis was enrolled
during the same year of study, the corresponding case
subject was left without a control pair. We failed to
control 11 depressive cases, because we found only 35
patients with depressive symptoms without a history of
suicide attempts in previous admissions. Exclusion criteria
for both groups included taking medication known to alter
lipid metabolism, dyslipemia, eating disorders and body
mass index \19 or current eating binges, to avoid cho-
lesterol and nutritional alterations due to these disorders.
Exclusion criteria for control group included any suicide
attempt in the past or recently. Patients with suicide
ideation or tanatic ideation without lifetime history of
suicide attempts were not excluded. All attempted suicide
patients did not have control pairs because of the exclu-
sion criteria.
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Procedures
Levels of cholesterol were obtained from the blood sam-
ples collected upon admission, after overnight fasting. All
blood samples were measured by the same laboratory,
using milligrams/deciliter (mg/dl). The normal range of
total cholesterol at our hospital is defined as 148–247 mg/
dl. The American Heart Association endorsed with guide-
lines of the National Cholesterol Education Program’s
Expert Panel on Blood Cholesterol in children and ado-
lescents (from 2 to 19 years) and determines as correct
total cholesterol levels as less than 170 mg/dl, borderline
from 170 to 199 mg/dl and high from 200 mg/dl or greater.
We did not find patients clearly outside the normal cho-
lesterol range. Socio-demographic data, clinical diagnoses,
psychotropic medication at admission in both groups and
suicide methods used by the suicidal group were recorded.
This study was approved by the Ethical Committee of
Hospital Clinic of Barcelona. This study was retrospective
and we did not have informed consent of the patients and
their families. However, Ethical Committee approved the
study because it did not imply any experimental procedure.
The blood samples were obtained from the usual screening
laboratory tests, carried out in all patients admitted at the
hospitalization unit.
Data analysis
Results were analyzed using descriptive statistics. A Kol-
mogorov–Smirnov test was used to test for the normality of
variables and then parametric tests were used, Student’s t
test for quantitative variables and v2 test for qualitative
variables. Statistical analyses were performed using SPSS
(14.0).
Results
Clinical characteristics and serum cholesterol levels in both
groups of patients are listed and compared in the Table 1.
There were no significant differences between the two
groups with respect to gender, age or psychiatric diagnosis
or in terms of antidepressant or antipsychotic medication at
admission; nor were there significant differences between
cholesterol levels in patients who were taking antipsychotic
medication at admission and those who were not (t = 0.8,
df = 23.3, p = 0.37), nor with respect to gender (t = 1.7,
df = 118, p = 0.08). Levels of cholesterol were signifi-
cantly lower in attempted suicide patients than in controls.
When only patients with a diagnosis of depression were
included, lower cholesterol levels were found in attempted
suicide patients, though the difference was not statistically
significant. If we focused on method of suicide attempts
and divide the suicide sample in two big groups, overdose-
suicide attempt (more frequent method) and non-overdose
suicide attempts, the differences in cholesterol levels were
not statistically significant (overdose-suicide attempt:
mean = 144.51, SD = 24.08; non-overdose suicide
attempts: mean = 152.42, SD = 27.21; t = 1.16, p =
0.249). We do not find patients clearly outside the normal
cholesterol range.
Discussion
This is the first study to point out an association between
suicide attempts and low levels of cholesterol in a psy-
chiatric adolescent inpatient sample with a range of psy-
chiatric disorders. Psychometric measures of suicidality
were not used in the study; however, confirmed and sub-
stantiated reports of suicide attempts were used as depen-
dent variables rather than potentially biased self-reports or
unsubstantiated verbal reports of suicidal behaviors.
This finding is similar to those of most adult studies that
have reported this association. Mean serum total choles-
terol level obtained in our subjects with suicide attempts
was similar with those reported by Kim et al. [19], and was
near the lower end of the range defined as normal at our
hospital. The study was not designed to identify a cutoff
point for cholesterol.
Although suicide risk is known to increase in the pres-
ence of a history of personal or family psychiatric disor-
ders, it has been shown that liability to suicidal behavior—
specifically, suicide attempts and completions—might be
familial transmitted as a trait independent of psychiatric
disorders [5]. As all subjects in our inpatient groups were in
the acute period of their illness, our findings support the
hypothesis that low levels of cholesterol might be associ-
ated with suicidal behavior. However, if lower blood
cholesterol levels help to predict suicide, we may wonder
whether this is the case in any psychiatric diagnosis. More
studies are needed with larger samples, in which all psy-
chiatric disorders are represented, to explore this issue
further. The serotonin–suicide–cholesterol relationship
might suggest that affective disorders involving serotonin
system dysfunction would be the psychiatric illnesses with
the highest rates of suicidality. However, studies with other
psychiatric disorders have also found this association,
raising the possibility that altered serotonin neurotrans-
mission may also be linked with cholesterol and suicide
with non-affective disorders. The findings are limited to
psychiatric child and adolescent patients and may not be
generalizable to other psychiatric patients.
Our study is limited due to the small sample size, which
reduces the statistical power required to establish sub-
groups and to confirm the association between suicidal
Eur Child Adolesc Psychiatry (2010) 19:615–619 617
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behavior and lower cholesterol levels in all psychiatric
diagnoses separately. Other limitations are the fact that we
did not monitor body mass index; patients were not
assessed with structured psychometric tests for suicidality,
and inferring causal relations with retrospective studies is
also problematic. If this association is replicated from
future studies with bigger samples and methodological
designs for studying cholesterol levels as a risk factor, this
parameter could help to add more information to the cli-
nicians to evaluated suicidal risk of our patients, in a
similar way as we asked for psychopathology and familiar
variables. Further studies assessing the relationship
between cholesterol-related biological and genetic factors
and suicide-related clinical factors are required to establish
the role of cholesterol in this complex human behavior.
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